DataArt in the News
The announcement of DataArt winning the 2017 Pfizer Healthcare Challenge award in Munich is covered by Pharma Relations, Germany’s leading healthcare and pharma magazine.
Founder Magazine runs the announcement of DataArt winning the 2017 Pfizer Healthcare Challenge award in Munich.
In Towards Data Science, Sergey Bludov, SVP in Media and Entertainment Practice at DataArt, explores the advances of artificial intelligence in the music ecosystem.
Fintech Finance Magazine covers the announcement of a blockchain event to be hosted by DataArt and management consultancy zeb in Munich on Nov. 22 where leading fintech and blockchain experts will discuss real-life examples of blockchain implementation.
In Plattform Life Sciences, a German life sciences journal, Anton Dolgikh, Head of AI at DataArt, discusses the role of artificial intelligence in clinical trials, namely its significant impact on targets search, hits/leads search, adverse effects reduction, and old drugs repositioning.
Cliff Moyce, Head of the Finance Practice at DataArt, contributes a bylined article to C Suite, where he outlines five reasons not to fear artificial intelligence (AI).
In Health IT Outcomes, Alexander Myskiw, Engagement Manager in the Healthcare and Life Sciences Practice at DataArt, explores the advent of tech giants, including Amazon, Apple and Google, into the healthcare sector, and the future industry dynamics.
In ITProPortal, Rafael Zubairov, Senior Architect at DataArt, explains how a business can start using machine learning without dedicated software engineers or data science experts, and reviews the tools that make it possible.
In Goingpublic.de, a German finance journal, Cliff Moyce, Finance Practice Leader at DataArt, discusses various threats to cybersecurity, their impact on banks’ reputation and strategies for counteracting them.